POLYMERASE CHAIN-REACTION FOR DIAGNOSIS OF VARICELLA-ZOSTER VIRUS CENTRAL-NERVOUS-SYSTEM INFECTIONS WITHOUT SKIN MANIFESTATIONS

Authors
Citation
T. Bergstrom, POLYMERASE CHAIN-REACTION FOR DIAGNOSIS OF VARICELLA-ZOSTER VIRUS CENTRAL-NERVOUS-SYSTEM INFECTIONS WITHOUT SKIN MANIFESTATIONS, Scandinavian journal of infectious diseases, 1996, pp. 41-45
Citations number
23
Categorie Soggetti
Infectious Diseases
ISSN journal
00365548
Year of publication
1996
Supplement
100
Pages
41 - 45
Database
ISI
SICI code
0036-5548(1996):<41:PCFDOV>2.0.ZU;2-Z
Abstract
Varicella tester virus (VZV) can cause disease in the central nervous system (CNS) during both primary infection and reactivation. Rapid and adequate diagnosis of VZV have previously been hampered by the shortc omings of standard virological methods, such as isolation and serology . Earlier reported cases of CNS manifestations of VZV infection have, therefore, mostly been noted in connection with, or shortly after, ons et of vesicular rash. Several studies have recently been described of cases of VZV-induced CNS disease occurring as the only sign of viral r eactivation, with the diagnosis aided by polymerase chain reaction (PC R) amplification and other methods of genome detection, A prospective study was performed using PCR on cerebrospinal fluid (CSF) and brain s amples received for routine diagnosis of possible VZV infection during a 2-year period. Samples from 8 (7 from CSF, 1 from brain) of the 260 patients investigated (3.1%) were found to be positive for VZV-DNA. A ll 8 had a presumed reactivated VZV infection according to serological and clinical analysis. Their CNS manifestations ranged from meningiti s to severe encephalitis, and only in 3 of these patients was a vesicu lar rash present. Thus, VZV-DNA detection in the CSF was an unexpected finding for the clinician and, in 2 cases, antiviral treatment with a liclovir was initiated only because of the PCR evidence of CNS infecti on. VZV should be considered as a possible causative agent of infectio n in patients with CNS disease of suspected viral origin, even in the absence of skin manifestations. Rapid diagnosis by PCR amplification o f VZV-DNA from CSF might allow for early and adequate antiviral treatm ent.